CEACAM5 and neoplasm: In this study, it was revealed that post/pre-treatment CEA ratio predicted TRG and tumor downstage in LARC patients received neoadjuvant therapy and higher post-treatment CEA predicted unfavored prognosis in LARC with elevated pre-treatment CEA.